← Leaderboards
Sukjoon Park
Emergent Product Development Gaithersbur
$31,572,885
Attributed
$31,572,885
Total exposure
5
Grants
5
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants. They are the sole PI on all grants (the two match).
Funding over time
peak $24.1M · FY2008–21$25M$18.8M$12.5M$6.3M$0
'08
'09
'10
'11
'12
'13
'14
'15
'16
'17
'18
'19
'20
'21
Funding mix
By agency
NIH$31,572,885 · 5
By mechanism
N01$23,027,895 · 2
U01$8,544,990 · 3
Top collaborators
No co-investigators on record.
Most similar at Emergent Product Development Gaithersbur
Same institution · by research overlap
- Ajoy Chakrabarti$1,624,359
- Robert Jay Hopkins$335,310
- Heidi Joyce Agostini$1,406,326
Others in their field
Top investigators on “Vaccines”
- Lawrence Corey · Fred Hutchinson Cancer Center$829,044,908
- Margaret Juliana McElrath · Fred Hutchinson Cancer Center$556,540,832
- Bambra Strokes · Ppd Development Lp$526,656,217
- Barton F Haynes · Duke University$515,215,260
- Glenda E Gray · Wits Health Consortium (Pty), Ltd$398,445,678
- Dennis R. Burton · Scripps Research Institute$316,106,418
Research focus
VaccinesCyclic GmpLicensingAnthrax VaccinesCaviaDoseSafetyPharmaceutical PreparationsImmune ResponseNext GenerationOligonucleotidesVaccine DevelopmentToxic EffectDrug FormulationsToxicologyBiothraxCharacteristicsAdjuvantResponseVaccinationGenerationsLicensureAnimalsImmunogenicity
Grant awards (11)
Development of an Anthrax Vaccine$2,562,540
N01 · FY2021 · AI · contact PI
Development of a Next Generation Anthrax Vaccine, AV7909$246,331
U01 · FY2012 · AI · contact PI
Development of a Next Generation Anthrax Vaccine, AV7909$309,989
U01 · FY2011 · AI · contact PI
Development of an Anthrax Vaccine$11,351,920
N01 · FY2010 · AI · contact PI
Development of Technologies to Facilitate the Use of and Response to Vaccines$9,113,435
N01 · FY2010 · AI · contact PI
Development of a Next Generation Anthrax Vaccine, dmPA7909$2,896,688
U01 · FY2010 · AI · contact PI
Bivalent Recombinant LHn Botulinum Vaccine (Serotypes A and B)$399,412
U01 · FY2010 · AI · contact PI
Development of a Next Generation Anthrax Vaccine, AV7909$304,363
U01 · FY2010 · AI · contact PI
Development of a Next Generation Anthrax Vaccine, dmPA7909$2,454,564
U01 · FY2009 · AI · contact PI
Development of a Next Generation Anthrax Vaccine, AV7909$462,222
U01 · FY2009 · AI · contact PI
Development of a Next Generation Anthrax Vaccine, AV7909$1,471,421
U01 · FY2008 · AI · contact PI